MedTrace Logo

Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

NCT00268177 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2016-09-15

No results posted yet for this study

Summary

This study was designed to look at effects of salmeterol/fluticasone propionate compared to placebo on airway inflammation in patients with chronic obstructive airways disease

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Salmeterol/fluticasone propionate 50/500mcg Diskus

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2003-12-31

Countries

  • Denmark
  • Estonia
  • Finland
  • Italy
  • Lithuania
  • Slovakia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00268177 on ClinicalTrials.gov